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Abstract
Background: Enterococcus faecalis is a significant cause of infective endocarditis, an infection of the heart endothelium
leading to vegetation formation (microbes, fibrin, platelets, and host cells attached to underlying endothelial tissue). Our
previous research determined that enterococcal aggregation substance (AS) is an important virulence factor in causation of
endocarditis, although endocarditis may occur in the absence of AS production. Production of AS by E. faecalis causes the
organism to form aggregates through AS binding to enterococcal binding substance. In this study, we assessed the ability
of IgGs and IgG Fabs against AS to provide protection against AS
+ E. faecalis endocarditis.
Methodology/Principal Findings: When challenged with AS
+ E. faecalis, 10 rabbits actively immunized against AS
+ E.
faecalis developed more significant vegetations than 9 animals immunized against AS
2 E. faecalis, and 9/10 succumbed
compared to 2/9 (p,0.005), suggesting enhanced aggregation by IgG contributes significantly to disease. IgG antibodies
against AS also enhanced enterococcal aggregation as tested in vitro. In contrast, Fab fragments of IgG from rabbits
immunized against purified AS, when passively administered to rabbits (6/group) immediately before challenge with AS
+ E.
faecalis, reduced total vegetation (endocarditis lesion) microbial counts (7.9610
6 versus 2.0610
5, p=0.02) and size (40 mg
versus 10, p=0.05). In vitro, the Fabs prevented enterococcal aggregation.
Conclusions/Significance: The data confirm the role of AS in infective endocarditis formation and suggest that use of Fabs
against AS will provide partial protection from AS
+ E. faecalis illness.
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Introduction
Enterococcus faecalis is a significant cause of infective endocarditis,
an infection of the endothelium of the heart [1,2]. The organism
has been known to cause endocarditis since the early 1900s, and is
now considered one of the most significant causes of endocarditis,
resulting in as many as 10–15% of cases [3,4]. The characteristic
endocarditis lesions are referred to as vegetations, which appear as
nodules containing microbes, fibrin, platelets, and host cells
attached to underlying endothelial tissue [3].
Previous studies have determined that enterococcal aggregation
substance (AS), although not required for enterococci to produce
endocarditis, when present contributes significantly to the ability of
E. faecalis to cause endocarditis [5,6,7]. AS is a large (137 kDa)
surface-exposed protein encoded by pheromone-responsive, con-
jugative plasmids. This protein contributes to formation of large
bacterial cell aggregates through binding to enterococcal binding
substance (EBS), a component of which appears to include
lipoteichoic acid [8]. The AS proteins comprise a family of surface
adhesins whose amino acid sequences are .90% identical through
most of the proteins, with exception of a small internal segment of
the protein that is more variable; our laboratories study Asc10, an
AS protein encoded by the plasmid pCF10 [9,10]. Through use of
isogenic strains, we have demonstrated that AS
+ E. faecalis cause
larger endocarditis vegetations with higher bacterial loads than
AS
2 organisms in a rabbit endocarditis model. The cumulative
results of analysis of Asc10 suggest that the protein has at least two
different functional activities in endocarditis pathogenesis, prob-
ably associated with different domains [8,10,11,12]. An N-
terminal domain confers bacterial aggregation and lipoteichoic
acid binding activity, and also plays a role in interactions of
enterococci with mammalian host cells [8]. In addition, the
protein contains two arginine-glycine-aspartic acid (RGD) motifs
potentially mediating interactions with integrins, and there is
suggestive evidence that these domains might be involved in
protection of enterococcal cells from killing by phagocytes [8,12].
In spite of the abundance of data for a contribution of AS to the
pathogenesis of enterococcal endocarditis, our studies have shown
that antibodies raised against a surface-exposed, N-terminal
domain of AS are not protective against endocarditis in a rabbit
model [6,13]. Multiple hypotheses have been presented to account
for lack of antibody protection. One of these states that antibodies
to AS may actually enhance virulence due to ability to promote
additional aggregation of enterococcal cells. This hypothesis was
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IgG Fab fragments against AS to provide protection against AS
+
E. faecalis endocarditis.
Results
Rabbits (3/group) were injected intravenously with AS
+ E.
faecalis strain OG1SSp carrying the plasmid pINY1801, expressing
the cloned AS gene (prgB) constitutively, or the isogenic AS
2 strain
OG1SSp carrying the same cloning vector plasmid (referred to as
pWM401) without the AS gene. The bacterial strains were
administered after 2 h of continuous damage to the aortic valves/
aortas by prior catheterization. After 4 additional days, the rabbits
were sacrificed and examined for vegetations. All animals had
visible vegetations, but those obtained from rabbits inoculated with
the AS
+ strain were larger and had higher bacterial loads than
animals receiving the AS
2 strain (Table 1), in agreement with
previous results [5,6,7,14]. An example of a rabbit aorta with
vegetations induced by the AS
+ strain is shown in Fig. 1
(vegetations are circled).
Rabbits (9 or 10 per group) were immunized against either E.
faecalis OG1SSp (pINY1801, AS
+) or isogenic E. faecalis OG1SSp
(pWM401, AS
2). The animals were then challenged with
OG1SSp (pINY1801, AS
+) to assess immunization against AS to
protect rabbits from infective endocarditis. The rabbits that had
been immunized with the AS
+ organism showed more significant
vegetations than those immunized against the AS
2 organism or
those animals that were not immunized (Table 2). In addition,
animals immunized with the AS
+ organism showed extensive lung
congestion, and all but one of the animals succumbed prior to the
end of the study; the 9 rabbits succumbed during day 2 of
experimentation. Collectively, these animals had vegetations of
sufficient size and numbers to obstruct their aortas. In contrast,
only 2 of the 9 animals immunized with the AS
2 organism
succumbed (also during day 2) when challenged with the AS
+
organism, and none succumbed in the non-immunized group.
Animals that had been immunized with the AS
2 organism had
signs of lung congestion, but not to the extent of animals
immunized against the AS
+ organism and challenged with AS
+
organism. The vegetations in the animals immunized with the
AS
2 organism, or those that were not immunized had moderate
size and numbers of vegetations.
It was hypothesized previously that antibodies raised against the
N-terminus of AS may enhance ability to cause endocarditis [6].
The above experiment in which rabbits were actively immunized
with killed OG1SSp (pINY1801, AS
+) organisms and then
challenged with viable OG1SSp (pINY1801, AS
+) also suggested
that antibodies to AS enhance disease. In order to test this
hypothesis more fully and to identify a potential therapeutic agent,
Fabs of hyperimmune IgG raised against purified AS were
prepared, confirmed by SDS-PAGE, and used passively in attempt
to prevent OG1SSp (pINY1801, AS
+) ability to cause endocarditis
(Table 3). The mean weight of vegetations of the rabbits treated
passively with Fabs was 10 mg, compared to 40 mg for animals
not receiving passive Fabs (p,0.05). There was a greater than two-
log difference in total log CFUs of enterococci in the vegetations
from the Fab treated rabbits compared to control animals
(p,0.02). There was no evidence of pulmonary congestion in
any of the Fab treated rabbits, but mild congestion was observed in
two of the 6 control animals; none of the 12 animals used in this
study prematurely succumbed.
The ability of IgG against AS to enhance the aggregation of AS
+
E. faecalis OG1SSp (pINY1801) in vitro and Fabs to inhibit
aggregation were assessed visually (Fig. 2). As expected, AS
+ E.
faecalis OG1SSp (pINY1801) spontaneously aggregated forming
moderate aggregates of bacteria at the bottom of the tube, but with
some bacteria remaining in the culture supernate. The aggregation
of AS
+ E. faecalis OG1SSp (pINY1801) was enhanced by IgG
antibodies to AS in that the aggregates of bacteria at the bottom of
the tube were larger, formed more quickly, and nearly completely
cleared the culture supernate. Fabs against AS completely
prevented visible aggregation of AS
+ E. faecalis OG1SSp
(pINY1801).
Discussion
Previous research by our group [5,6,8,13,14] and by other
investigators [15] suggests that enterococcal AS is an important
virulence factor in causation of infective endocarditis. However,
the factor is not required for inducing endocarditis, as AS
2
organisms also have the ability to induce illness [5,14]. We
previously showed that isogenic AS
2 organisms cause more
inflammation pericardially compared to AS
+ organisms when both
organisms are injected into the hearts of rabbits [5,14]. These data
suggest there are different pathways that lead to vegetation
formation, one in which there is significant activation of the host
immune system to clear the organism, as with the AS
2 organism,
Figure 1. Enterococcus faecalis OG1SSp (pINY1801, AS
+) infec-
tious endocarditis aortic valve and aortic vegetations. Vegeta-
tions are circled.
doi:10.1371/journal.pone.0013194.g001
Table 1. Enterococcal aggregation substance enhances vegetation production in endocarditis in rabbits.
Treatment Group Number of Rabbits Mean Vegetation Weight (mg) P-Value Mean Log CFU Total in Vegetations P-Value
OG1SSp (AS
+) 3 62 7.7
OG1SSp (AS
2) 3 39 0.04 5.6 0.03
doi:10.1371/journal.pone.0013194.t001
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level immune system activation, possibly due to formation of
aggregates, as with the AS
+ organism.
Having established that AS contributes to the virulence of E.
faecalis through our studies and those of others, we attempted to
interfere with AS activity, and thus, possibly reduce the severity of
endocarditis. One observable phenotypic function of AS is
aggregate formation through interaction with EBS that includes
lipoteichoic acid [8]. It could then be hypothesized that further
aggregate formation through reaction of IgG antibodies with AS,
with or without complement fixation, might increase the severity
of endocarditis. This was observed in our studies. In addition, the
formation of very large aggregates would be expected to obstruct
small capillaries, such as those in the lungs, leading to pneumonia-
like symptoms. This was also observed in rabbits immunized with
both AS
+ and AS
2 organisms and challenged with AS
+ organisms
(the lung congestion was greater in animals immunized with the
AS
+ organisms). With this as background, we evaluated the ability
of Fabs of IgG antibodies raised specifically against AS to interfere
with endocarditis. We studied Fabs of IgG rather than F(ab’)2
molecules since Fabs lack ability to both cross-link antigens and fix
complement, whereas F(ab’)2 molecules retain ability to cross-link
antigens, though they have lost ability to fix complement. We first
raised IgG antibodies against a secreted form of intact AS [8], then
partially purified the IgGs and made Fabs. These Fabs, when
passively administered intravenously to rabbits immediately before
challenge with AS
+ organisms, reduced both vegetation size and
CFUs of enterococci in vegetations. The in vivo effects of IgG and
Fabs against AS were confirmed by in vitro tests in which IgGs
enhanced enterococcal aggregation and Fabs completely inter-
fered with aggregation.
The studies are significant for two reasons: 1) the ability of AS to
induce aggregation is important in endocarditis formation,
although endocarditis may occur in their absence (as observed
with the AS
2 organisms); and 2) use of passive Fabs against surface
microbial virulence factors in general may be more effective than
IgGs against the same virulence factors. Thus, for example, other
organisms that cause significant endocarditis include S. aureus and
viridans streptococci. These organisms have many cell-surface
virulence factors referred to as microbial surface components
recognizing adhesive matrix molecules (MSCRAMMs), at least
some of which lead to aggregate formation [16]. Attempts are
underway to develop antibody-based vaccines against the
organisms by targeting surface virulence factors, including
MSCRAMMs [17]. It is possible that such antibodies would be
more effective if administered as Fabs that prevent aggregate
formation.
Materials and Methods
Plasmids and Bacteria
The plasmid pWM401 is a broad-host range cloning vector;
pINY1801 contains a cloned fragment of pCF10, including the
Asc10-encoding prgB gene [18]. It has been previously shown that
E. faecalis strains carrying pINY1801 produce AS constitutively (5,
14). Isogenic E. faecalis strains OG1SSp (pINY1801) and OG1SSp
(pWM401, differing only in production of AS, were used as the test
organisms for immunization and production of endocarditis [5].
The organisms were cultured overnight in a dialyzable beef heart
medium [19], washed one time with PBS, and resuspended to
1610
9 CFU/ml in PBS; 2 ml were injected intravenously into the
marginal ear veins of rabbits for endocarditis production [5].
OG1SSp (pINY1801) was verified as AS
+ by its ability to form
visible aggregates during growth; OG1SSp (pWM401) lacked the
ability to form aggregates. Bacterial strains were stored as
lyophilized stock cultures in the laboratory until used.
Antiserum and Fabs
Hyperimmune antiserum against AS was prepared by immu-
nization of rabbits against purified AS [8] emulsified in Freund’s
incomplete adjuvant (Sigma Aldrich, St. Louis, MO). This serum
was determined experimentally to have a titer (reciprocal of last
reactive wells in 96 well microtiter plates) against AS of 2500/ml,
as determined by ELISA. The IgG fraction of this antibody was
prepared by ammonium sulfate precipitation (final ammonium
sulfate concentration 34%) and resolubilization in PBS. The
Table 2. Active immunization against AS
+ E. faecalis worsens infectious endocarditis after challenge with AS
+ enterococci.
Rabbits Immunized
Against: Alive/Total Tested
P-Value Compared to AS
+ E. faecalis
Immunized Animals
a 2 Vegetations
b 2
Respiratory
Condition
AS
+ E. faecalis 1/10 3+ pneumonia
None 5/5 0.002 2+ Normal
AS
2 E. faecalis 7/9 0.005 2+ pneumonia
a 2Determined with use of Fishers Exact Test.
b 21+ vegetations were small in size and number (approximately 10 mg); 2+ vegetations were moderate in size and number (approximately 50 mg); and 3+ vegetations
were large in size and numbers, often obstructing the aorta (.75 mg).
doi:10.1371/journal.pone.0013194.t002
Table 3. IgG Fabs against aggregation substance reduce the severity of enterococcal endocarditis after challenge with AS
+ E.
faecalis.
Treatment Group Number of Rabbits
Mean Vegetation
Weight (mg) P-Value
Mean Log CFU Total in
Vegetations P-Value
Control 6 40 6.9
Fab Treated 6 10 0.05 4.3 0.02
doi:10.1371/journal.pone.0013194.t003
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remove residual ammonium sulfate, and the resultant IgG fraction
was digested to completion with papain to generate Fabs.
Complete digestion was verified by SDS-PAGE in non-reducing
gels [20] as demonstrated through loss of the IgG fraction and
appearance of a strong band with a molecular weight of
approximately 50,000.
Each rabbit receiving Fab fragments was injected intravenously
with the equivalent of approximately 2.5 ml of original hyperim-
mune antiserum. Assuming the injected rabbits had blood volumes
of approximately 50 ml, each rabbit received sufficient Fabs to
achieve titers of 125/ml blood.
In one in vitro experiment, 0.5 ml of ammonium sulfate
fractionated IgG against AS or 0.5 ml of Fabs against AS were
mixed with 0.5 ml volumes of stationary phase cultures of AS
+ E.
faecalis OG1SSp (pINY1801) for 30 min at room temperature and
then examined visually for degree of aggregation.
Immunization Against Enterococci
E. faecalis OG1SSp (pINY1801, AS
+) and OG1SSp (pWM401,
AS
2) were cultured to stationary phase in beef heart medium. The
organisms were washed one time with PBS and adjusted to
2610
9 CFU/ml in PBS and killed by heat (65uC, 30 min) and
then gentamicin (100 ug/ml, 1 h, 37uC). The cells (0.5 ml
amounts) were emulsified with equivalent amounts of Freund’s
incomplete adjuvant and administered subcutaneously in the nape
of the neck to rabbits (9 or 10 per test organism). The animals were
injected 3 times separated by two week intervals and then used for
challenge with AS
+ E. faecalis OG1SSp (pINY1801) to assess the
ability of active immunization to provide protection against
infective endocarditis. Prior to challenge, the rabbits were
evaluated for antibody titers against the corresponding organisms
with use of ELISA. Wells of Nunc-Immuno plates were coated
with 100 ul/well of 2610
9 CFU/ml of the immunizing entero-
cocci for use in antibody titer determination. Average antibody
titers to the immunizing enterococci, whether AS
+ E. faecalis
OG1SSp (pINY1801) or AS
2 E. faecalis OG1SSp (pWM401), were
.10,000, compared to #10 for preimmune sera.
Experimental Endocarditis
All animal studies were performed in accordance with
requirements established by the University of Minnesota Institu-
tional Animal Care and Use Committee, with specific approval
given for this work under protocol 0910A73332 (project name
Biofilms and Enterococcus faecalis Biology). Healthy New Zealand
white rabbits, either sex and weighing approximately 2 kg, were
obtained from Bakkom Rabbitry, Red Wing, MN. After
acclimating to the University of Minnesota animal facilities for
approximately one week, the rabbits as the model animal for
infective endocarditis [5] were challenged with E. faecalis. Briefly,
rabbits were anesthetized with ketamine and xylazine for a total of
approximately 4 h. The left carotid artery of each animal was
surgically exposed, a catheter (outside diameter 1.27 mm) was
inserted into the carotid to cause damage to the aortic valve for
2 h, each catheter was then removed, each carotid was ligated, the
neck incision was closed, and each animal was challenged
intravenously with viable organisms through the left marginal
ear vein. Animals were sacrificed on day 4 with a lethal injection of
Beuthanasia D, and hearts were resected. Vegetations were
exposed, photographed, aseptically removed, weighed, and
homogenized in PBS for quantitative bacterial counts.
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